4.8 Article

Screening for lung cancer: 2023 guideline update from the American Cancer Society

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

A Quick Reference Guide for Incidental Findings on Lung Cancer Screening CT Examinations

Debra S. Dyer et al.

Summary: The US Preventive Services Task Force has recommended low-dose CT screening for lung cancer since 2013. Many incidental findings are detected during the screening. The authors created a quick reference guide to assist healthcare providers in managing these incidental findings.

JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2023)

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Letter Medicine, General & Internal

Prevalence of Lung Cancer Screening Among Eligible Adults in 4 US States in 2021

Kristin G. Maki et al.

JAMA NETWORK OPEN (2023)

Article Critical Care Medicine

Pulmonary Nodules, Lung Cancer Screening, and Lung Cancer in the Medicare Population

Paul Pinsky et al.

Summary: This study explores the relationship between pulmonary nodules and lung cancer, assessing the commonness of nodules in the Medicare population and the rate of lung cancer after their detection. The study finds that pulmonary nodules are relatively common and are associated with a higher occurrence of lung cancer. It also suggests that a larger proportion of early-stage lung cancer is diagnosed through reporting of nodules compared to low-dose CT scan screening.

CHEST (2023)

Review Oncology

Lung cancer diagnosis and mortality beyond 15 years since quit in individuals with a 20+pack-year history: A systematic review

Karli K. Kondo et al.

Summary: This study aimed to understand the lung cancer risk among individuals who quit smoking for 15 years or more and examined their incidence, risk, and mortality compared to never smokers. The findings suggest a gradual decline in lung cancer risk after 15 years of quitting smoking, but no significant difference before and after that period. The study also found that the outcomes after 15 years of quitting were similar between African American/Black and White participants, but increasing the years since quitting would have a greater impact on eligibility for White individuals.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Article Oncology

Absolute lung cancer risk increases among individuals with >15 quit-years: Analyses to inform the update of the American Cancer Society lung cancer screening guidelines

Rebecca Landy et al.

Summary: This study quantifies the effects of quit-years and concomitant aging on lung cancer risk, showing that the risk continues to increase beyond 15 quit-years. It suggests that exempting or curtailing lung cancer screening for individuals with more than 15 quit-years is not supported. Augmenting the quit-year criterion with the LYFS-CT prediction model can prevent more deaths with higher efficiency.

CANCER (2023)

Editorial Material Oncology

Time to quit using quit time as a lung cancer screening eligibility criterion

Martin Carl Tammemagi

Summary: Multiple lines of reasoning and evidence, including the study by Meza and colleagues, suggest that the use of the <= 15 quit-years rule for lung cancer screening eligibility should be abandoned.

CANCER (2023)

Article Oncology

Assessing the impact of increasing lung screening eligibility by relaxing the maximum years-since-quit threshold. A simulation modeling study

Rafael Meza et al.

Summary: Expanding lung cancer screening to include individuals who formerly smoked and have quit smoking for more than 15 years would result in considerable increases in deaths averted and life-years gained. Although a modest increase in additional harms would occur, these could be moderated by ensuring that screening is restricted only to those with reasonable life expectancy.

CANCER (2023)

Letter Medicine, General & Internal

Estimating Pack-Year Eligibility for Lung Cancer Screening Using 2 Yes or No Questions

Katharine A. Rendle et al.

JAMA NETWORK OPEN (2023)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Geographic access to lung cancer screening among eligible adults living in rural and urban environments in the United States

Liora Sahar et al.

Summary: This study examines access to lung cancer screening nationwide and across rural and urban settings. Geographic information system network analysis is used to estimate access at different distances, and the results show disparities in accessibility between regions and across rural and urban environments. Approximately 5% of the eligible population does not have access to screening facilities within 40 miles, and rural areas have a larger proportion of the population with no access.

CANCER (2022)

Article Oncology

NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022

Douglas E. Wood et al.

Journal of the National Comprehensive Cancer Network (2022)

Article Critical Care Medicine

Oncology Care Provider Training in Empathic Communication Skills to Reduce Lung Cancer Stigma

Smita C. Banerjee et al.

Summary: Empathy-based, stigma-reducing communication training for oncology care providers can improve communication skills, reduce patient stigma, increase patient satisfaction, and lead to better assessments of smoking history and smoking cessation treatment.

CHEST (2021)

Article Oncology

Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines

Rebecca Landy et al.

Summary: The draft 2020 USPSTF guidelines increased eligibility for lung cancer screening among minorities and Whites by similar proportions compared to the 2013 guidelines. However, the relative disparity in gainable life-years from screening between eligible Whites and minorities actually increased with the 2020 guidelines. Using the LYFS-CT model could help reduce disparities in screening eligibility by identifying high-benefit individuals regardless of race and ethnicity.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Editorial Material Oncology

Lung Cancer Stigma Then and Now: Continued Challenges Amid a Landscape of Progress

Heidi A. Hamann et al.

JOURNAL OF THORACIC ONCOLOGY (2021)

Review Medicine, General & Internal

Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement

Alex H. Krist et al.

Summary: Lung cancer is the second most common cancer and leading cause of cancer death in the US, with smoking and increasing age being the primary risk factors. Annual screening with low-dose computed tomography is recommended for adults aged 50 to 80 years with a 20 pack-year smoking history.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Medicine, General & Internal

Screening for Lung Cancer With Low-Dose Computed Tomography Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Daniel E. Jonas et al.

Summary: Screening high-risk individuals with LDCT can decrease lung cancer mortality but may also result in false positives, overdiagnosis, incidental findings, distress, and rarely radiation-induced cancers. More research is needed to optimize nodule evaluation protocols to minimize harms associated with screening.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Medicine, General & Internal

Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography Modeling Study for the US Preventive Services Task Force

Rafael Meza et al.

Summary: The study modeled the benefits and harms of LDCT screening for lung cancer, finding that starting at age 50 or 55 with a smoking history of 20 pack-years or more had more benefits compared to the 2013 USPSTF recommendations, but also resulted in more false-positive results, overdiagnosed cases, and radiation-related lung cancer deaths.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Oncology

Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening

Iakovos Toumazis et al.

Summary: The study found that the 2021 USPSTF recommendation for lung cancer screening was cost-effective compared to the 2013 recommendation, but expanding screening eligibility to include former smokers who have quit for more than 15 years may further improve cost-effectiveness. Alternative screening strategies with a minimum cumulative smoking exposure of 20 pack-years, including individuals who quit within the past 25 years, were found to be more cost-effective than the 2021 recommendation.

JAMA ONCOLOGY (2021)

Article Public, Environmental & Occupational Health

Women screened for breast cancer are dying from lung cancer: An opportunity to improve lung cancer screening in a mammography population

Kim L. Sandler et al.

Summary: This study found that a portion of women who underwent breast cancer screening in 2015 were also eligible for lung cancer screening, and implementing lung cancer screening led to some women being diagnosed with lung cancer.

JOURNAL OF MEDICAL SCREENING (2021)

Review Oncology

Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review

Ernesto Sosa et al.

Summary: This study investigates the inequalities in lung cancer screening (LCS) and finds significant disparities along racial and socioeconomic lines. Black and socioeconomically disadvantaged individuals miss out on potential benefits of LCS along the pipeline, resulting in increased mortality rates.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Critical Care Medicine

Screening for Lung Cancer CHEST Guideline and Expert Panel Report

Peter J. Mazzone et al.

Summary: Evidence suggests that low-dose CT screening for lung cancer can result in a favorable balance of benefit and harms. Factors such as the selection of screen-eligible individuals, the quality of imaging and image interpretation, the management of screen-detected findings, and the effectiveness of smoking cessation interventions can impact this balance.

CHEST (2021)

Article Oncology

Selection of individuals for lung cancer screening based on risk prediction model performance and economic factors-The Ontario experience

Martin C. Tammemagi et al.

Summary: Utilizing the PLCOm2012 risk prediction model can effectively select individuals for lung cancer screening, improving cancer detection rate and increasing early stage cancer diagnosis among patients.

LUNG CANCER (2021)

Article Oncology

Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial

Nikolaus Becker et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Article Public, Environmental & Occupational Health

Understanding lung cancer screening behaviour using path analysis

Lisa Carter-Harris et al.

JOURNAL OF MEDICAL SCREENING (2020)

Editorial Material Oncology

Basing Eligibility for Lung Cancer Screening on Individualized Risk Calculators Should Save More Lives, but Life Expectancy Matters

Hormuzd A. Katki et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)

Article Oncology

Disparities of National Lung Cancer Screening Guidelines in the US Population

Summer S. Han et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)

Article Medicine, General & Internal

Increasing Cancer Screening Rates in Primary Care

Richard Wender et al.

MEDICAL CLINICS OF NORTH AMERICA (2020)

Article Primary Health Care

Barriers, Facilitators, and Suggested Interventions for Lung Cancer Screening Among a Rural Screening-Eligible Population

Jenna E. Schiffelbein et al.

JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2020)

Article Environmental Sciences

Survival to Age 90 in Men: The TromsO Study 1974-2018

Tormod Brenn

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)

Article Oncology

Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial

Denise R. Aberle et al.

JOURNAL OF THORACIC ONCOLOGY (2019)

Article Oncology

Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study

Hilary A. Tindle et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Review Oncology

Multilevel Opportunities to Address Lung Cancer Stigma across the Cancer Control Continuum

Heidi A. Hamann et al.

JOURNAL OF THORACIC ONCOLOGY (2018)

Article Oncology

Lifetime Smoking History and Risk of Lung Cancer: Results From the Framingham Heart Study

Hilary A. Tindle et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)

Article Oncology

Lung Cancer Mortality Mortality in the Lung Screening Study Feasibility Trial

Maryam Doroudi et al.

JNCI CANCER SPECTRUM (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium

Constance D. Lehman et al.

RADIOLOGY (2017)

Article Critical Care Medicine

Impact of a Lung Cancer Screening Counseling and Shared Decision-Making Visit

Peter J. Mazzone et al.

CHEST (2017)

Article Medicine, General & Internal

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening

Hormuzd A. Katki et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Review Public, Environmental & Occupational Health

Impact of provider-patient communication on cancer screening adherence: A systematic review

Emily B. Peterson et al.

PREVENTIVE MEDICINE (2016)

Review Medicine, General & Internal

Breast Cancer Screening for Women at Average Risk 2015 Guideline Update From the American Cancer Society

Kevin C. Oeffinger et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)

Article Public, Environmental & Occupational Health

Lung cancer risk by years since quitting in 30+pack year smokers

Paul F. Pinsky et al.

JOURNAL OF MEDICAL SCREENING (2015)

Article Public, Environmental & Occupational Health

A note on the design of cancer screening trials

Stephen W. Duffy et al.

JOURNAL OF MEDICAL SCREENING (2015)

Article Oncology

Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-Year Smokers: Implications for Screening

Paul F. Pinsky et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Oncology

Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-Year Smokers: Implications for Screening

Paul F. Pinsky et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Article Medicine, General & Internal

Overdiagnosis in Low-Dose Computed Tomography Screening for Lung Cancer

Edward F. Patz et al.

JAMA INTERNAL MEDICINE (2014)

Article Oncology

American Cancer Society Lung Cancer Screening Guidelines

Richard Wender et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2013)

Article Health Care Sciences & Services

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations

Jeff Andrews et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)

Article Medicine, General & Internal

Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer

Timothy R. Church et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Review Medicine, General & Internal

Prognostic Indices for Older Adults A Systematic Review

Lindsey C. Yourman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Review Public, Environmental & Occupational Health

Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review

Donella Puliti et al.

JOURNAL OF MEDICAL SCREENING (2012)

Editorial Material Medicine, General & Internal

Shared Decision Making - The Pinnacle of Patient-Centered Care

Michael J. Barry et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Radiology, Nuclear Medicine & Medical Imaging

Estimated Radiation Dose Associated With Low-Dose Chest CT of Average-Size Participants in the National Lung Screening Trial

Frederick J. Larke et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2011)

Article Medicine, General & Internal

New American Cancer Society Process for Creating Trustworthy Cancer Screening Guidelines

Otis Brawley et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Health Care Sciences & Services

GRADE guidelines: 9. Rating up the quality of evidence

Gordon H. Guyatt et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Health Care Sciences & Services

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

Gordon Guyatt et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Medicine, General & Internal

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Denise R. Aberle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Oncology

Baseline Characteristics of Participants in the Randomized National Lung Screening Trial

Denise R. Aberle et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)

Article Oncology

Lung cancer screening as a teachable moment for smoking cessation

Kathryn L. Taylor et al.

LUNG CANCER (2007)

Article Public, Environmental & Occupational Health

Benefits of smoking cessation for longevity

DH Taylor et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2002)